ArticleNature communications2022

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice.

Anneliese S Ashhurst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.